A previous study evaluated the effects of EPO on RGCs in episcleral vessel cautery-induced rats with glaucoma using 200ng EPO, which found no significant decrease in the RGC of the EPO-treated group [40–42]. The gene discussed is EPO; the disease is glaucoma.